Retinoic acid signaling in myelopoiesis
Retinoic acid signaling in myelopoiesis
复制标题
DOI:
10.1097/moh.0b013e3282f20a9c
复制
发表时间:
2008-01-01
影响因子:
3.2
通讯作者:
Rosmarin, Alan
中科院分区:
文献类型:
--
作者:
Drumea, Karen;Yang, Zhong-fa;Rosmarin, Alan
Purpose of reviewFor decades, retinoic acid has been known to alter the proliferation and differentiation of myeloid cells. Currently, retinoic acid is a front-line agent in the treatment of certain forms of acute myelogenous leukemia. In this review, we focus on recent advances in our understanding of the mechanisms by which retinoids affect growth and proliferation of myeloid cells and contribute to the pathogenesis of leukemia. We have not attempted to summarize the related clinical literature.Recent findingsThe past 2 years have yielded important understanding of the mechanisms by which retinoids and their nuclear receptors interact with other signal transduction pathways and transcription factors to modify chromatin, alter gene expression, and participate in normal myeloid differentiation and leukemogenesis. Important advances regarding cell biology, molecular biology, biochemistry, and animal studies of retinoids and myeloid differentiation are reviewed.SummaryGreater understanding of the role of retinoids and their receptors in myeloid cell growth and differentiation provides important insight into normal myelopoiesis. These findings have resulted in successful rational approaches to the treatment of acute leukemia and provide the promise of improved treatments in the near future.